Optimizing Manufacturing Costs and Aseptic Processing for ATMPs: Delving into Cost Efficiency and Quality Maintenance

Summary It is expensive to transition from an academic research and development status to GMP advanced therapy medicinal product (ATMP) production. Some of the major cost drivers in this transition are initial start-up costs due to equipment, starting and raw materials, experienced personnel and adv...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy